| 0% | In every instance where the schedule does not provide a zero percent evaluation for a diagnostic code, a zero percent evaluation shall be assigned when the requirements for a compensable evaluation are not met. | Your lung cancer has been treated and you have no lasting effects on your lung function. A 0% rating establishes service connection. The lowest compensable level under this code is 10 percent. |
|---|
What supports this level- Cancer in remission confirmed by oncology
- Normal pulmonary function tests after treatment
- Normal chest imaging with no active disease
- Clearance from treating oncologist
|
| 10% | FEV-1 of 71- to 80-percent predicted, or; FEV-1/FVC of 71 to 80 percent, or; DLCO (SB) 66- to 80-percent predicted. | After treatment, your breathing tests show FEV-1 of 71 to 80 percent predicted, or FEV-1/FVC of 71 to 80 percent, or DLCO (SB) of 66 to 80 percent predicted. |
|---|
What supports this level- FEV-1 of 71-80% predicted on post-bronchodilator PFT
- FEV-1/FVC ratio of 71-80%
- DLCO (SB) of 66-80% predicted
- Post-treatment pulmonary function testing
|
| 30% | FEV-1 of 56- to 70-percent predicted, or; FEV-1/FVC of 56 to 70 percent, or; DLCO (SB) 56- to 65-percent predicted. | After treatment, your breathing tests show FEV-1 of 56 to 70 percent predicted, or FEV-1/FVC of 56 to 70 percent, or DLCO (SB) of 56 to 65 percent predicted. |
|---|
What supports this level- FEV-1 of 56-70% predicted on PFT
- FEV-1/FVC ratio of 56-70%
- DLCO (SB) of 56-65% predicted on PFT
- Cancer remission documented
|
| 60% | FEV-1 of 40- to 55-percent predicted, or; FEV-1/FVC of 40 to 55 percent, or; DLCO (SB) of 40- to 55-percent predicted, or; maximum oxygen consumption of 15 to 20 ml/kg/min (with cardiorespiratory limit). | After treatment, your breathing tests show FEV-1 of 40 to 55 percent predicted, or FEV-1/FVC of 40 to 55 percent, or DLCO (SB) of 40 to 55 percent predicted, or maximum oxygen consumption of 15 to 20 ml/kg/min. |
|---|
What supports this level- FEV-1 of 40-55% predicted on PFT
- DLCO (SB) of 40-55% predicted on PFT
- Maximum oxygen consumption of 15 to 20 ml/kg/min on exercise testing
- Shortness of breath with moderate activity
- Evidence of surgical lung tissue loss (lobectomy/pneumonectomy)
|
| 100% | A rating of 100 percent shall continue beyond the cessation of any surgical, X-ray, antineoplastic chemotherapy or other therapeutic procedure. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e) of this chapter. If there has been no local recurrence or metastasis, rate on residuals. | Your cancer is active or under treatment, in which case DC 6819 assigns 100% and continues it past the end of treatment until a mandatory VA examination six months later. Separately, post-treatment residuals reach 100% when breathing tests show FEV-1 or DLCO (SB) less than 40 percent predicted, or you have cor pulmonale, an episode of acute respiratory failure, or require outpatient oxygen therapy. |
|---|
What supports this level- Lung cancer diagnosis confirmed by biopsy or pathology
- Active treatment records (surgery, chemotherapy, radiation)
- Date of last treatment, for the six-month examination clock
- FEV-1 or DLCO (SB) less than 40% predicted on post-treatment PFT
- Cor pulmonale, right ventricular hypertrophy, or pulmonary hypertension
- Outpatient oxygen therapy prescription
|